DPY19L1-NRXN2 Fusion FISH Probe
The DPY19L1-NRXN2 Fusion FISH Probe is used to confirm a fusion of the DPY19L1 and NRXN2 genes. The fusion of the DPY19L1 and NRXN2 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
SKU | Test Kits | Buffer | Dye Color | Order Now |
---|---|---|---|---|
DPY19L1-NRXN2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-RERE | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-REOR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-REGO | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-REGR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-REAQ | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-ORRE | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-OROR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-ORGO | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-ORAQ | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GORE | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GOOR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GOGO | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GOGR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GOAQ | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GRRE | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GROR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GRGO | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GRGR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-GRAQ | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-AQRE | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-AQOR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-AQGO | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-AQGR | 20 (40 μL) | 200 μL | ||
DPY19L1-NRXN2-20-AQAQ | 20 (40 μL) | 200 μL |
NRXN2 Gene Summary
This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]
Gene Name: Neurexin 2
Chromosome: CHR11: 64373645 -64490660
Locus: 11q13.1
DPY19L1 Gene Summary
The Dpy-19 Like C-mannosyltransferase 1 (DPY19L1) gene is located on chr7 :34968492-35077653 at 7p14.2.
Gene Name: Dpy-19 Like C-mannosyltransferase 1
Chromosome: CHR7: 34968492 -35077653
Locus: 7p14.2
Gene Diseases
The DPY19L1 NRXN2 Fusion has been associated with the following diseases:
Disease Name |
---|
Breast Invasive Carcinoma |
FISH Probe Protocols
Protocol, Procedure, or Form Name | Last Modified | Download |
---|